ArticleJournal of nanobiotechnology2026
Targeted inhibition of ITK activity with anti-CD3 antibody-modified calcium silicate nanoparticles loaded with novel 7H-Pyrrolo[2,3-d]pyrimidine derivatives for treating aplastic anemia.
Xia Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.